Hangzhou Tigermed Consulting Co. Ltd. is buying Frontage Laboratories Inc. from Baird Capital.

The Exton, Pennsylvania-based target provides bioanalysis, preclinical studies, early phase clinical studies and product development services to biopharmaceutical companies. Frontage has facilities in the U.S. and China. The company will operate as a subsidiary of Hangzhou Tigermed, and retain its management team and facilities.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.